- Infectious Diseases Therapeutics
- cancer therapeutics
- Dermatology therapeutics
- Ophthalmology therapeutics
- Hematology Therapeutics
- Gastrointestinal therapeutics
- Women's Health therapeutics
- Dental Therapeutics
- Neurology therapeutics
- Respiratory therapeutics
- Diabetes Therapeutics
- Men's Health therapeutics
- Cardiovascular therapeutics
- Central Nervous System (CNS) therapeutics
- Urology therapeutics
- Kidney
- Sexually Transmitted Diseases Therapeutics
- Metabolic therapeutics therapeutics
- Pulmonary therapeutics
- Orthopedic therapeutics
- Arthritis therapeutics
- Oral Therapeutics
- Allergy therapeutics
- ENT Therapeutics
- Radiology therapeutics
- Hiv/Aids Therapeutics
Therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Cutaneous T-Cell Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharm......" | 30-Apr-2021 | $2000 | |
Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... mprehensive information on the therapeutics under development for Hutchinson-Gilford Progeria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also co......" | 30-Apr-2021 | $2000 | |
Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... sease pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Dementia Associated With Alzheimer's Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Act......" | 30-Apr-2021 | $2000 | |
Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... nsive information on the therapeutics under development for Maple Syrup Urine Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the......" | 30-Apr-2021 | $2000 | |
Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... therapeutics under development for Angelman Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Act......" | 30-Apr-2021 | $2000 | |
Dental Caries (Mouth And Dental Disorders) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Dental Caries, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological A......" | 30-Apr-2021 | $2000 | |
Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... peutics under development for Turner Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of t......" | 30-Apr-2021 | $2000 | |
Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021By Global Markets Direct "...... sive information on the therapeutics under development for Mycobacterium Infections, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the d......" | 30-Apr-2021 | $2000 | |
Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s comprehensive information on the therapeutics under development for Diabetic Neuropathic Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also ......" | 30-Apr-2021 | $2000 | |
Primary Hyperoxaluria Type I (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... andscape.
The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria Type I, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 30-Apr-2021 | $2000 | |
|